Global PCOS Diagnostic Market Size To Exceed USD 6.1 Billion By 2033

Global PCOS Diagnostic Market Size To Exceed USD 6.1 Billion By 2033 | CAGR Of 5.18%

The Global PCOS Diagnostic Market Size was Valued at USD 3.68 Billion in 2023 and the Worldwide PCOS Diagnostic Market Size is Expected to Reach USD 6.1 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: Abbott, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Vitrolife, Ansh Labs, Beckman Coulter, Inc., GE Healthcare, Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd, Quest Diagnostics, Siemens Healthineers, Hologic, Inc., Myriad Genetics, Inc., Diagnostica Stago Inc., and other key vendors. The Global PCOS Diagnostic Market Size was Valued at USD 3.68 Billion in 2023 and the Worldwide PCOS Diagnostic Market Size is Expected to Reach USD 6.1 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: Abbott, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Vitrolife, Ansh Labs, Beckman Coulter, Inc., GE Healthcare, Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd, Quest Diagnostics, Siemens Healthineers, Hologic, Inc., Myriad Genetics, Inc., Diagnostica Stago Inc., and other key vendors.

New York, United States , June 27, 2024 (GLOBE NEWSWIRE) -- The Global PCOS Diagnostic Market Size is to Grow from USD 3.68 Billion in 2023 to USD 6.1 Billion by 2033, at a CAGR of 5.

18% during the projected period. PCOS diagnostics is the process of identifying and assessing women who have polycystic ovarian syndrome (PCOS), an imbalance in their hormones. The ovaries and adrenal glands typically develop small levels of androgens, or male sex hormones, which support the reproductive system's regular function.

But in a woman with PCOS, the ovaries, the adrenal glands, or both overproduce androgens. This can lead to several symptoms, including obesity, acne, and an abundance of face and body hair. Numerous procedures, including blood tests, pelvic ultrasounds, and pelvic exams, are used to diagnose PCOS.

Several drugs are used to manage the menstrual cycle and treat the symptoms of PCOS, even though there is no known cure for the disorder. Hereditary abnormalities, low-grade inflammation, ovarian cysts, elevated levels of testosterone, and excessive insulin are some of the other causes. One of the main factors propelling the market for PCOS diagnostics is the growing prevalence of PCOS.

Additionally, people and healthcare professionals are becoming more knowledgeable about PCOS and the potential health risks associated with it. Furthermore, improvements in diagnostic technology, like as genetic testing, ultrasonography, and hormonal assays, have improved the precision and effi.